about Zydus | contact us | home       
Bioequivalence Chart
Warfarin Tablet Identification Chart
Medication Guide
Package Insert


Healthcare Provider Information

Zydus Pharmaceuticals (USA) Inc. appreciates your interest in our product and we have included this information to assist you in managing your patient’s anticoagulation therapy.

Indications of Zydus Warfarin Sodium Tablets, USP

Indicated for prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE).

Indicated for prophylaxis and treatment of thromboembolic complications associated with atrial fibrilation (AF) and/or cardiac valve replacement.

Indicated to reduce the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

Bioequivalence Chart

Results of Zydus' bioequivalencey study:

Warfarin Tablet Identifacton Chart

This tablet identification chart is a helpful comparison chart which shows Zydus Warfarin Sodium Tablets, USP have similar colored tablets to Coumadin® and other generic warfarin sodium tablets in all 9 strengths.



Please refer to the full package insert for complete prescribing information.

Coumadin® is a registered trademark of Bristol-Myers Squibb Company

Healthcare Providers Patient Information Pharmacist Information FAQs
  About Zydus Contact Us    
Copyright � 2008 Zydus Pharmaceuticals (USA) Inc. All rights reserved.











DHTML Menu / JavaScript Menu - Created Using NavStudio (OpenCube Inc.)